The use of designer drugs has risen severely in recent years. Among others, synthetic cannabinoids and synthetic cathinones have been recognized as the largest categories of new drugs identified in Europe last year [1]. Synthetic cannabinoids are novel psychoactive substances that imitate the effects of cannabis, while synthetic cathinones belong to phenylalkylamine group of drugs with characteristics similar to amphetamines. Their production appears to take place primarily in China and India. The drugs are then imported into Europe, where they are packaged and marketed as ‘legal highs’ or sold in the illicit market [1,2].
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1PGH7P7
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου